http://today.reuters.com/business/newsarticle.aspx ?type=heal... By Ben Hirschler, European Pharmaceuticals Correspondent LONDON, June 7 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research) agreement on Wednesday to buy Britain's NeuTec Pharma Plc (NTP.L: Quote, Profile, Research) for an eye-popping 109 percent stock premium shows just how hungry big pharma is for drugs ...


